MRVI · TickerCove

MRVIMaravai LifeSciences Holdings, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $6.84 · now $6.84 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, MRVI has typically landed between $4.87 and $8.98 — a range of −28.8% to +31.4% from the issuance price $6.84.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,438 overlapping 1 month windows · 2020-11-20 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($6.84) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$6.84 · 66% of range

$2.69 low$9 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−2.7%

typical move · IQR 23.8%

−28.8%worst (p90)+31.4%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where MRVI has typically landed a month from the 2026-09-16 close of $6.84 — the range is history, not a prediction.

now $6.84 (+0.0%)
typical $6.65 (-2.7%)
middle 50% $5.84–$7.47
90% range $4.87–$8.98

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,438 windows spanning 2020-11-20 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2024-10-21	−45.5%	−48.0%	+0.0%
2024-10-18	−45.5%	−47.1%	+1.8%
2024-10-17	−45.5%	−45.5%	+4.8%
3 best
2024-02-21	+66.5%	−2.9%	+66.5%
2024-02-22	+66.1%	+0.0%	+71.4%
2026-04-09	+55.9%	−1.6%	+55.9%

1,438 overlapping windows · 2020-11-20 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

50%

−3.7%

n=6

Feb

67%

+5.6%

n=6

Mar

33%

−7.5%

n=6

Apr

33%

+1.8%

n=6

May

67%

+6.4%

n=6

Jun

50%

+3.1%

n=6

Jul

50%

+4.4%

n=6

Aug

50%

+3.1%

n=6

Sep

33%

+0.3%

n=6

Oct

20%

−16.3%

n=5

Nov

40%

−7.1%

n=5

Dec

17%

+0.2%

n=6

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-06-10	ORESHACK KURT	officer	Sale	25,000 @ $5.10	$127K	−6.9% of holding	+21.7%	not yet — horizon still open	335,767	Form 4 · filed same day
2026-06-09	ORESHACK KURT	officer	Sale	25,000 @ $5.06	$126K	−6.5% of holding	+16.7%	not yet — horizon still open	360,767	Form 4 · filed 1 day after the trade
2025-12-08	LUCIER GREGORY T	director	Purchase	48,528 @ $3.67	$178K	+45.5% of holding	+5.5%	+34.0%	155,123	Form 4 · filed 1 day after the trade
2025-12-05	LUCIER GREGORY T	director	Purchase	51,472 @ $3.70	$190K	+93.4% of holding	+3.5%	+29.7%	106,595	Form 4 · filed 4 days after the trade
2025-11-13	Brust Bernd	director	Purchase	216,212 @ $3.25	$703K	+86.3% of holding	+11.6%	+15.0%	466,771	Form 4 · filed 4 days after the trade
2025-11-12	Brust Bernd	director	Purchase	93,358 @ $3.21	$300K	+59.4% of holding	+11.0%	+18.9%	250,559	Form 4 · filed 1 day after the trade
2025-11-11	Brust Bernd	director	Purchase	157,201 @ $3.24	$509K	ownership Δ n/a	+13.3%	+21.8%	157,201	Form 4 · filed 2 days after the trade
2025-01-31	ORESHACK KURT	officer	Sale	25,000 @ $5.03	$126K	−13.0% of holding	−38.2%	−59.5%	167,618	Form 4 · filed same day

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

74 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-09-08	Brust Bernd	director	Withheld for tax	29,250	1,561,249	Form 4
2026-08-31	Asarpota Rajesh	director	Withheld for tax	5,465	423,486	Form 4
2026-08-10	Brust Bernd	director	Withheld for tax	29,250	1,590,499	Form 4
2026-07-30	Asarpota Rajesh	director	Withheld for tax	5,465	428,951	Form 4
2026-07-08	Brust Bernd	director	Withheld for tax	29,250	1,619,749	Form 4
2026-06-30	Asarpota Rajesh	director	Withheld for tax	65,584	434,416	Form 4
2026-06-09	LUCIER GREGORY T	director	Gift	46,293	155,123	Form 4
2026-06-09	LUCIER GREGORY T	director	Gift	46,293	156,077	Form 4
2026-06-08	Brust Bernd	director	Withheld for tax	351,001	1,648,999	Form 4
2026-05-26	LUCIER GREGORY T	director	Award / grant	46,293	201,416	Form 4
2026-05-26	GRAY SUSANNAH	director	Award / grant	46,293	216,200	Form 4
2026-05-26	MIHAS CONSTANTINE S	director	Award / grant	46,293	184,348	Form 4
2026-05-26	MARKER LUKE JOSEPH	director	Award / grant	46,293	184,348	Form 4
2026-05-26	DeFord John A	director	Award / grant	46,293	205,478	Form 4
2026-05-26	ECKERT R ANDREW	director	Award / grant	46,293	412,183	Form 4
2026-05-26	CUNNINGHAM SEAN LAURENCE	director	Award / grant	46,293	184,348	Form 4
2026-05-15	Dolan Christine	officer	Award / grant	5,006	425,318	Form 4
2026-05-15	ORESHACK KURT	officer	Award / grant	776	385,767	Form 4
2026-03-16	ORESHACK KURT	officer	Withheld for tax	39,976	384,991	Form 4
2026-03-16	Dolan Christine	officer	Withheld for tax	28,661	420,312	Form 4
2026-01-15	ORESHACK KURT	officer	Withheld for tax	31,902	424,967	Form 4
2026-01-15	Dolan Christine	officer	Withheld for tax	28,934	448,973	Form 4
2025-11-14	Dolan Christine	officer	Award / grant	4,300	477,907	Form 4
2025-07-15	Leddy Peter Michael	officer	Withheld for tax	5,154	727,177	Form 4
2025-07-10	LUCIER GREGORY T	director	Gift	89,139	109,784	Form 4
2025-07-10	LUCIER GREGORY T	director	Gift	89,139	55,123	Form 4
2025-06-30	Asarpota Rajesh	director	Award / grant	333,333	333,333	Form 4
2025-06-30	Asarpota Rajesh	director	Award / grant	750,000	750,000	Form 4
2025-06-30	Asarpota Rajesh	director	Award / grant	500,000	500,000	Form 4
2025-06-30	Asarpota Rajesh	director	Award / grant	500,000	500,000	Form 4
2025-06-16	ECKERT R ANDREW	director	Award / grant	231,481	365,890	Form 4
2025-06-16	CUNNINGHAM SEAN LAURENCE	director	Award / grant	89,139	138,055	Form 4
2025-06-16	Hopfield Jessica	director	Award / grant	89,139	199,907	Form 4
2025-06-16	DAVERMAN BENJAMIN JAMES	director	Award / grant	89,139	138,055	Form 4
2025-06-16	DeFord John A	director	Award / grant	89,139	159,185	Form 4
2025-06-16	PRAHALAD MURALI	director	Award / grant	89,139	154,607	Form 4
2025-06-16	MARKER LUKE JOSEPH	director	Award / grant	89,139	138,055	Form 4
2025-06-16	GRAY SUSANNAH	director	Award / grant	89,139	169,907	Form 4
2025-06-16	LUCIER GREGORY T	director	Award / grant	89,139	144,262	Form 4
2025-06-16	MIHAS CONSTANTINE S	director	Award / grant	89,139	138,055	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i